Alpha Tau Medical Ltd
DRTS3.020USD
+0.040+1.34%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
212.94MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Alpha Tau Medical Ltd Unternehmen
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Unternehmensinformationen
BörsenkürzelDRTS
Name des UnternehmensAlpha Tau Medical Ltd
IPO-datumMar 08, 2022
CEOMr. Uzi Sofer
Anzahl der mitarbeiter125
WertpapierartOrdinary Share
GeschäftsjahresendeMar 08
AddresseKiryat Hamada 5
StadtJERUSALEM
BörseNASDAQ Capital Market Consolidated
LandIsrael
Postleitzahl9777605
Telefon97235774115
Websitehttps://www.alphatau.com/
BörsenkürzelDRTS
IPO-datumMar 08, 2022
CEOMr. Uzi Sofer
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Gary Leibler
Mr. Gary Leibler
Independent Director
Independent Director
--
--
Mr. Alan Adler
Mr. Alan Adler
Independent Director
Independent Director
--
--
Dr. S. Morry Blumenfeld, Ph.D.
Dr. S. Morry Blumenfeld, Ph.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.55M
+0.17%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
504.27K
+0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Oramed Pharmaceuticals Inc
16.66%
Sofer (Uzi)
13.60%
Avruch (Michael)
1.83%
Keisari (Yona)
0.60%
HoyleCohen, LLC
0.32%
Other
67.00%
Aktionäre
Aktionäre
Anteil
Oramed Pharmaceuticals Inc
16.66%
Sofer (Uzi)
13.60%
Avruch (Michael)
1.83%
Keisari (Yona)
0.60%
HoyleCohen, LLC
0.32%
Other
67.00%
Aktionärstypen
Aktionäre
Anteil
Corporation
16.66%
Individual Investor
16.26%
Investment Advisor
0.96%
Investment Advisor/Hedge Fund
0.68%
Hedge Fund
0.07%
Bank and Trust
0.04%
Venture Capital
0.03%
Other
65.30%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
54
29.39M
34.70%
+13.97M
2025Q1
56
19.44M
23.97%
-491.93K
2024Q4
55
19.31M
27.55%
-2.82M
2024Q3
59
19.28M
27.51%
-4.37M
2024Q2
62
19.31M
27.55%
-4.87M
2024Q1
65
19.84M
28.32%
-4.33M
2023Q4
137
22.06M
31.83%
-24.51M
2023Q3
140
32.52M
46.94%
-14.56M
2023Q2
146
33.02M
48.83%
-14.67M
2023Q1
145
32.68M
48.37%
-16.77M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Oramed Pharmaceuticals Inc
14.11M
16.66%
+14.11M
--
Apr 24, 2025
Sofer (Uzi)
11.52M
13.6%
--
--
Mar 01, 2025
Avruch (Michael)
1.55M
1.83%
+2.71K
+0.17%
Mar 01, 2025
Keisari (Yona)
504.27K
0.6%
+781.00
+0.16%
Mar 01, 2025
HoyleCohen, LLC
269.09K
0.32%
--
--
Jun 30, 2024
Hightower Advisors, LLC
230.70K
0.27%
--
--
Mar 31, 2025
Kovitz Investment Group Partners, LLC
226.32K
0.27%
+194.06K
+601.44%
Mar 31, 2025
Levin Capital Strategies, L.P.
222.51K
0.26%
-92.00K
-29.25%
Mar 31, 2025
Milch (David Mark)
88.74K
0.1%
-2.00K
-2.20%
Mar 01, 2025
Gat (Amnon)
68.47K
0.08%
--
--
Mar 01, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
Amplify BlueStar Israel Technology ETF
0%
Amplify BlueStar Israel Technology ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
